Module Code
CHM2007
Summary of lecture content
Introduction to Medicinal Chemistry (7 Lectures/ 1 Seminar):
This course will introduce the key concept of medicinal chemistry, and underpin student’s learning for their subsequent medicinal chemistry topics/modules.
Protein-drug interactions.
Introduction to small molecule metabolism.
Toxicity and toxic alerts
Hit to Lead and Lead optimisation.
Assay development and Use
Targets and proteins (Dr Joe Vyle 11 Lectures and 1 Seminar)
Basic methodologies (5 Lectures):
• DNA synthesis / amplification.
• Chemical Synthesis.
• Enzymatic synthesis.
• Amplification by PCR.
• Epigenetic modifications of DNA.
Target Identification and Validation (6 Lectures):
• Genomics approaches
o mRNA knockdown
o RNA amplification.
o Quantification by QPCR.
o RNA interference / CRISPR/ CAS9.
• DNA and DNA modification analysis:
o Sequencing
Chemical (Maxam-Gilbert);
Enzymatic (Sanger)
New methodologies.
• Proteomics
o Mass spectrometry;
o Side-chain modification (+ MS identification)
Isoforms phosphorylation / ubiquitination / palmitoylation / glycosidation
Covalent drug-target interactions
Modelling and Drug Development (Dr Meilan Huang, 10 lectures and 1 Seminar)
• QSAR (3 lectures):
• Quantitative Structure Activity Relationships (QSAR):-Hydrophobicity, electronic & steric factors (Taft and Hammett relationships)
• QSAR analysis (Craig plots, Topliss schemes, Hansch analysis),
• 3D-QSAR
•
Bioisosterism(3 lectures):
• Isosterism and Bioisosterism
• Peptidomimetics
Fragment based drug design (4 lectures)
• Drug Design: protein structure prediction, protein-ligand docking methods, structure-based drug design, ligand-based drug design,
• Focused combinatorial library design
• Protein-protein interactions.
Upon completion of this module, the students
• will have gained a general understanding of the process underlying drug discovery ranging from biological (target identification) to chemical (chemical structure optimisation) issues.
• The students will also have been exposed to examples of and the application of synthetic organic chemistry used for total synthesis of biologically-relevant target molecules and the sites and mechanisms of drug action.
Skills associated with the module:
Learners are expected to demonstrate the following on completion of the module:
• Subject specific skills in the context of medicinal chemistry in addition to problem-solving skills related to drug design and drug discovery.
Assessment
• 50% Final examination (excludes Quantum theory and atomic structure lectures)
• 20% Open book test (Quantum theory and atomic structure lectures only)
• 15% Practical (HPLC (Dr Doherty) and atomic spectrum (Dr Vyle))
• 10% Library project (Dr J Vyle)
• 5% Tutorial (three classes)
• Note: both the exam and total coursework elements must be passed at 40%.
Course Requirements: Compulsory elements consist of practicals and tutorials, with a 100% attendance at practicals required.
Coursework
20%
Examination
80%
Practical
0%
20
CHM2007
Spring Semester
12 Weeks
None